{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:28:50Z","timestamp":1789086530831,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["journals.elsevierhealth.com","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.eururo.2013.08.018","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T11:01:21Z","timestamp":1377169281000},"page":"733-739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Results from a Prospective Observational Study of Men with Premature Ejaculation Treated with Dapoxetine or Alternative Care: The PAUSE Study"],"prefix":"10.1016","volume":"65","author":[{"given":"Vincenzo","family":"Mirone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Arcaniolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Bull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Aquilina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Verze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2013.08.018_bib0005","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.eururo.2010.02.020","article-title":"Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation","volume":"57","author":"Hatzimouratidis","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.08.018_bib0010","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1743-6109.2010.02097.x","article-title":"Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials","volume":"8","author":"McMahon","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2013.08.018_bib0015","unstructured":"Assessment report for Priligy and associated names. European Medicines Agency Web site. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Priligy_29\/WC500124578.pdf."},{"key":"10.1016\/j.eururo.2013.08.018_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11587660-000000000-00000","article-title":"Cardiovascular safety profile of dapoxetine during the premarketing evaluation","volume":"11","author":"Kowey","year":"2011","journal-title":"Drugs R D"},{"key":"10.1016\/j.eururo.2013.08.018_bib0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1756287212453866","article-title":"Dapoxetine: a new option in the medical management of premature ejaculation","volume":"4","author":"McMahon","year":"2012","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.eururo.2013.08.018_bib0030","unstructured":"Annex III. Summary of product characteristics, labelling, and package leaflet. European Medicines Agency Web site. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Priligy_29\/WC500124577.pdf."},{"key":"10.1016\/j.eururo.2013.08.018_bib0035","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(06)69373-2","article-title":"Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials","volume":"368","author":"Pryor","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2013.08.018_bib0040","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1464-410X.2008.08165.x","article-title":"Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial","volume":"103","author":"Kaufman","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2013.08.018_bib0045","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.eururo.2009.01.025","article-title":"Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries","volume":"55","author":"Buvat","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.08.018_bib0050","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1743-6109.2009.01560.x","article-title":"Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine","volume":"7","author":"McMahon","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2013.08.018_bib0055","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1111\/j.1743-6109.2010.01820.x","article-title":"Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials","volume":"7","author":"Porst","year":"2010","journal-title":"J Sex Med"},{"issue":"347","key":"10.1016\/j.eururo.2013.08.018_bib0060","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJMoa012407","article-title":"Incidence and prognosis of syncope","volume":"19","author":"Soteriades","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2013.08.018_bib0065","first-page":"25","article-title":"The prevalence and incidence of medical conditions in healthy pharmaceutical company employees who volunteer to participate in medical research","volume":"48","author":"Singh","year":"1999","journal-title":"Br J ClinPharmacol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283813008464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283813008464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T16:23:48Z","timestamp":1539447828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283813008464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0302283813008464"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2013.08.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718095628.793539510","asserted-by":"object"}]},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Results from a Prospective Observational Study of Men with Premature Ejaculation Treated with Dapoxetine or Alternative Care: The PAUSE Study","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2013.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}